LSE - Delayed Quote GBp

Beximco Pharmaceuticals Limited (BXP.L)

Compare
39.10
+0.60
+(1.56%)
At close: 4:13:38 PM GMT
All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
7,353,234.32
8,364,466.32
6,084,786.86
5,214,176.45
6,023,263.96
Operating Cash Flow
--
--
6,084,786.86
5,214,176.45
--
Investing Cash Flow
-2,175,212.61
-2,406,458.61
-2,617,017.63
-7,680,054.42
-2,524,645.85
Financing Cash Flow
-5,283,632.54
-6,259,873.54
-3,560,570.81
2,615,225.20
-3,458,168.02
End Cash Position
838,266.17
854,105.65
1,135,686.18
1,168,673.82
675,466.61
Capital Expenditure
-1,961,907.32
-2,234,557.32
-2,710,027.66
-2,939,497.99
-2,558,417.72
Free Cash Flow
5,391,326.99
6,129,908.99
3,374,759.20
2,274,678.46
3,464,846.24
6/30/2021 - 10/21/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade